Clinical trials
Phase 2 Thrombocytopenia trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Amgen | 1 |
| Associazione Qol-one | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Mario Negri Institute for Pharmacological Research | 1 |
| Novartis Pharmaceuticals | 1 |
| UCB Biopharma SRL | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 10 |
| Myelodysplastic Syndromes | 2 |
| Anemia | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Fallopian Tube Neoplasms | 1 |
| Hepatitis C | 1 |
| Hepatitis C, Chronic | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lung Neoplasms | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.